Kyverna Therapeutics

Details

  • Unternehmenstyp
    Mittelständisches Unternehmen

Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for autoimmune diseases. The company is driven by core values of innovation and collaboration, focusing on advancing novel engineered T cell therapies to address unmet medical needs.

>